Cargando…
Characterizing Tumor Thrombus Arising from Non–Clear Cell Renal Cell Carcinoma
BACKGROUND: Renal cell carcinoma (RCC) can exhibit a unique vascular tropism that enables tumor thrombus extension into the inferior vena cava (IVC). While most RCC subtypes that form tumor thrombi are of clear cell (cc) histology, non–clear cell (ncc) subtypes can also exhibit this unique growth pa...
Autores principales: | Rabinowitz, Matthew J., Esfandiary, Tina, Cheaib, Joseph, Patel, Sunil H., Alam, Ridwan, Metcalf, Meredith, Enikeev, Dmitry, Pierorazio, Phillip M., Ged, Yasser M.A., Allaf, Mohamad E., Singla, Nirmish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638762/ https://www.ncbi.nlm.nih.gov/pubmed/36353070 http://dx.doi.org/10.1016/j.euros.2022.07.001 |
Ejemplares similares
-
Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
por: Gulati, Sakshi, et al.
Publicado: (2014) -
Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy
por: Hoeh, Benedikt, et al.
Publicado: (2022) -
Advanced renal cell carcinoma and COVID-19 — a personal perspective
por: Ged, Yasser, et al.
Publicado: (2020) -
Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging Malignancy
por: Drobner, Jake, et al.
Publicado: (2023) -
Early Treatment With Olmesartan Prevents Juxtamedullary Glomerular Podocyte Injury and the Onset of Microalbuminuria in Type 2 Diabetic Rats
por: Sofue, Tadashi, et al.
Publicado: (2012)